Details for Patent: 5,595,978
✉ Email this page to a colleague
Summary for Patent: 5,595,978
Title: | Composition and method for treatment of CMV retinites |
Abstract: | This invention concerns compositions and methods for the treatment of CMV infections. A composition including an antisense oligonucleotide targeted to the IE2 gene of CMV and a pharmaceutically acceptable carrier were used stop progression in CMV retinitis. |
Inventor(s): | Draper; Kenneth G. (Boulder, CO), Chapman; Sharon K. (Carlsbad, CA), Kisner; Daniel L. (Cardiff, CA) |
Assignee: | Isis Pharmaceuticals, Inc. (Carlsbad, CA) |
Application Number: | 08/233,711 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 5,595,978
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,595,978
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
PCT/US91/05815 | Aug 14, 1991 |
International Family Members for US Patent 5,595,978
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 154947 | ⤷ Try a Trial | |||
Austria | 159025 | ⤷ Try a Trial | |||
Austria | 160353 | ⤷ Try a Trial | |||
Austria | 168561 | ⤷ Try a Trial | |||
Austria | 186072 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |